University Of Vermont

This pilot study tests whether offering financial incentives (contingency management) can help people who started medication for opioid use disorder in the emergency department keep attending outpatient treatment. Thirty adults will be randomly assigned to receive either standard…

This study compares two different dosing schedules of the blood thinner apixaban (Eliquis) against no blood thinner in about 996 cancer patients at moderate risk for blood clots. Participants take either 2.5 mg twice daily, 5 mg once daily, or no anticoagulant for 6 months. The g…

This study looks at whether sending free meals to the home can improve food security for adults who are on medication for opioid use disorder. Forty participants will either get nutrition education alone or education plus weekly meal deliveries for 24 weeks. Researchers will trac…

This study looks at whether a therapy called prolonged exposure, given through video calls, can help people with both opioid use disorder and PTSD. About 135 adults on stable medication for opioid use will take part. The goal is to see if this approach improves therapy attendance…

This study tests whether a type of talk therapy called prolonged exposure therapy, plus small financial rewards for attending sessions, can reduce PTSD symptoms in pregnant women. Thirty pregnant women with PTSD will receive weekly therapy for 12 weeks. Researchers will measure s…

This study tests a short, pre-surgery rehab program for people who smoke and have a lung nodule that may be cancer. About 20 participants will do breathing exercises and get help to stop smoking. The goal is to see if this program is practical and can improve fitness, reduce symp…

This study tests whether daily symptom reporting via an app, website, or phone, plus follow-up calls from a nurse practitioner, can better manage chemotherapy-induced peripheral neuropathy (nerve damage). 422 adults who have completed certain chemotherapies will track symptoms fo…

This study tests a drug called fezolinetant, already approved for hot flashes in menopausal women, to see if it can reduce hot flashes in men with prostate cancer who are on hormone-lowering therapy. About 32 men will take the drug daily for 28 days. The goal is to measure how mu…

This study tests whether a new treatment approach called TINLL (Think in Nerve Length and Layers) works better than traditional therapy for tennis elbow. 68 adults with lateral elbow pain will be assigned to either TINLL or standard care based on their past treatments. Both group…

This study aims to understand why people with myelodysplastic syndromes (MDS), a type of blood cancer, are more likely to develop heart disease or stroke. Researchers will measure inflammation-related proteins in the blood of 30 adults with MDS over 6 months to see if these marke…

This study is testing how two different types of dietary fats affect brain function in healthy adults aged 65 to 75. Participants will follow a low-fat diet for one week, then switch to either a Mediterranean-style diet (high in oleic acid) or a typical North American diet (high …